GnRHa for trigger and luteal phase support in natural cycle frozen embryo transfer - A proof of concept study.
Itai Bar Hava, Hadar Yafee, Yeela Omer...
https://pubmed.ncbi.nlm.nih.gov/32741721/Actively Recruiting
Led by Fundacion Dexeus · Updated on 2026-10-15
154
Participants Needed
5
Research Sites
N/A
Total Duration
Researchers are conducting a non-inferiority randomized controlled trial to compare subcutaneous triptorelin and intranasal nafarelin for triggering final oocyte maturation in women undergoing fertility preservation cycles with oocyte cryopreservation. The study aims to determine if intranasal nafarelin is not significantly less effective than subcutaneous triptorelin in producing mature oocytes, with a focus on the number of mature metaphase 2 oocytes collected. This trial is sponsored by Fundacion Dexeus and focuses on women aged 18 to 40 undergoing ovarian stimulation. Participants receive progesterone-primed ovarian stimulation using any commercially available gonadotropin preparation. Once they have at least three follicles 18 mm or larger, they are randomly assigned to one of two groups. One group receives 200 micrograms of subcutaneous triptorelin 34 to 36 hours before planned oocyte collection, while the other group receives 800 micrograms of intranasal nafarelin at the same time before collection. During the study, participants undergo hormonal monitoring including serum FSH, LH, and progesterone levels around the trigger and oocyte retrieval times. Researchers record the total and mature oocytes retrieved, incidence of ovarian hyperstimulation syndrome, participant-reported pain, medication ease of use, preference, and adverse events. The primary outcome is measured until study completion, which lasts on average 10 to 20 days. Participants are closely monitored throughout the ovarian stimulation and retrieval process to assess safety and effectiveness signals.
CONDITIONS
Intranasal Nafarelin For Triggering Oocyte Maturation
N
Nikolaos P Polyzos, MD, PhD
I
Ignacio Rodríguez, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fundacion Dexeus
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 10 to 20 days
Participants undergo ovarian stimulation and receive either subcutaneous triptorelin or intranasal nafarelin to trigger final oocyte maturation before egg collection.
1 medication administration and monitoring until oocyte retrieval
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Itai Bar Hava, Hadar Yafee, Yeela Omer...
https://pubmed.ncbi.nlm.nih.gov/32741721/Mohamed A F M Youssef, Fulco Van der Veen, Hesham G Al-Inany...
https://pubmed.ncbi.nlm.nih.gov/25358904/Abraham Golan, Ariel Weissman
https://pubmed.ncbi.nlm.nih.gov/19573287/Itai Bar-Hava, Yossi Mizrachi, Daphne Karfunkel-Doron...
https://pubmed.ncbi.nlm.nih.gov/27114332/Fundacion Dexeus
Lead Sponsor